Published by La Vanguardia 2015-12-15. Oncomatryx expands capital to complete the preclinical phase of drugs against tumor stroma The Basque company Oncomatryx has completed a round of capital increase of
LAUREANO SIMON, Oncomatryx CEO, declares war on tumor microenvironment. “We envysion a new era where cancer in general and invasive tumors in particular will be beaten with orchestrated combinations of precision
6th World ADC Summit. 8th-10th February 2016. Berlin (Germany). ONCOMATRYX will be attending World ADC Berlin. Poster Presentation: “OMTX705, a powerful stroma-targeting ADC to treat invasive tumors” by Myriam Fabre, PhD. If you
Tumor microenvironment: A cancer key player to be fired Novel precision drugs that target the tumor microenvironment are entering the battlefield against cancer. Recent advances in the prevention and treatment
10.12.2012 12:33 Uni Stuttgart und Oncomatrix starten Forschungskooperation Andrea Mayer-Grenu Abteilung Hochschulkommunikation Universität Stuttgart Neuer Krebsmedikamente für die Behandlung metastasierender Tumore Das spanische Biopharmazeutik-Unternehmen Oncomatrix und die Universität Stuttgart haben
Publisehed by El Dato Magazine el 2013-01-01 New treatments against the most invasive cancer Develops in collaboration with renowned public and private national and foreign companies, new drugs that help to
The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.